XIENCE Sierra™ 1550300-08Recalls & reported problems
Abbott Vascular Inc. · XIENCE Sierra™ Everolimus Eluting Coronary Stent System 3.00 mm x 08 mm / Rapid-Exchange · Class 3 · Implant
All models of XIENCE Sierra (56)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 10
- Deaths reported
- 0
- Injuries reported
- 6
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 10 adverse event reports that list this exact device (DI 08717648227233), received between Mar 11, 2019 and Sep 3, 2021 — classified as 6 injuries, 4 malfunctions.
The most frequently reported specific device problem is “Device Dislodged or Dislocated” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem6
- Device Dislodged or Dislocated2
- Failure to Advance2
- Improper or Incorrect Procedure or Method2
- Deformation Due to Compressive Stress1
- Difficult to Insert1
- Difficult to Remove1
- Material Separation1
Patient problems
- No Consequences Or Impact To Patient4
- Angina3
- No Code Available2
- Stenosis2
- Dyspnea1
- No Clinical Signs, Symptoms or Conditions1
- Unspecified Infection1
- Vasoconstriction1
Recent adverse event reports
The 10 most recent of 10 reports, in the reporter's own words as published by the FDA.
MalfunctionSep 3, 2021Difficult to Remove; Failure to Advance; Difficult to Remove; Failure to Advance
IT WAS REPORTED THIS WAS A PROCEDURE TO TREAT A MODERATELY CALCIFIED AND MODERATELY TORTUOUS LEFT CIRCUMFLEX. A 3.0X8MM XIENCE SIERRA DRUG ELUTING STENT (DES) WAS INSERTED. HOWEVER, PRIOR TO REACHING THE LESION, HEAVY RESISTANCE WAS FELT. THEREFORE, THE PHYSICIAN DECIDED TO REMOVE THE DEVICE. IT WAS NOTED THAT DUE TO THE ANATOMY, RESISTANCE WAS FELT DURING REMOVAL. ONCE REMOVED, NO DEVICE DAMAGE WAS OBSERVED. A NEW DEVICE WAS INSERTED, AND THE PROCEDURE WAS SUCCESSFULLY PERFORMED. THERE WERE NO ADVERSE PATIENT EFFECTS AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12422689 ↗InjuryNov 13, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
PATIENT ID: (B)(6). IT WAS REPORTED THAT ON (B)(6) 2019 A 3.0 X 08 MM AND A 3.5 X 23 MM XIENCE SIERRA STENT WERE IMPLANTED IN THE PROXIMAL LEFT ANTERIOR DESCENDING (LAD) ARTERY, IN OVERLAPPING FASHION, WITH THE 3.0 X 8 MM XIENCE SIERRA IMPLANTED DISTAL TO THE 3.5 X 23 MM XIENCE SIERRA. ON (B)(6) 2020, THE PATIENT WAS RE-HOSPITALIZED WITH CHEST PAIN. CORONARY ANGIOGRAPHY NOTED LESIONS IN THE PROXIMAL AND MID LAD AND A LESION IN THE POSTERIOR DESCENDING ARTERY (PDA). A DRUG ELUTING STENT WAS IMPLANTED IN THE PDA. ON (B)(6) 2020, A STAGED PROCEDURE WAS PERFORMED IN THE LAD, WITH IN-STENT RESTENOSIS NOTED IN THE 3.0 X 8 MM XIENCE SIERRA STENT. BALLOON DILATATION WAS PERFORMED AND AN ADDITIONAL DRUG ELUTING STENT WAS IMPLANTED TO TREAT THE RESTENOSIS. MEDICATION WAS ADMINISTERED AND ADJUSTED. THE ADVERSE EVENT RESOLVED ON (B)(6) 2020. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: Angina; Stenosis
MAUDE report 10840899 ↗InjurySep 21, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
PATIENT ID: (B)(6). IT WAS REPORTED THAT ON (B)(6) 2020 TWO XIENCE SIERRA STENTS (3.0X8, 3.0X23) WERE IMPLANTED IN THE FIRST DIAGONAL (D1) CORONARY ARTERY. ON (B)(6) 2020 THE PATIENT HAD CHEST PAIN. THE STENT WAS PATENT, BUT BOTH STENTS WERE PINCHING THE LEFT ANTERIOR DESCENDING (LAD) CORONARY ARTERY. ACCORDING TO THE PHYSICIAN, THIS WAS NOT AN OCCLUSION. ANGIOPLASTY WAS PERFORMED WITH A KISSING BALLOON TECHNIQUE TO THE LAD AND D1. THE PATIENT HAD GOOD RESULTS AND THE CONDITION RESOLVED THE SAME DAY. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: Angina; Vasoconstriction
MAUDE report 10560242 ↗InjuryAug 6, 2020Improper or Incorrect Procedure or Method; Failure to Advance; Device Dislodged or Dislocated; Improper or Incorrect Procedure or Method; Failure to Advance; Device Dislodged or Dislocated
IT WAS REPORTED THAT THE PROCEDURE WAS PERFORMED TO TREAT A LESION WITH HEAVY CALCIFICATION AND MILD TORTUOSITY IN THE MID RIGHT CORONARY ARTERY (MRCA). DURING ADVANCEMENT OF A 3.0 X 8MM XIENCE SIERRA STENT DELIVERY SYSTEM (SDS), RESISTANCE MET WITH THE HEAVY CALCIFICATION AND THE STENT COULD NOT CROSS THE TARGET LESION. THEREFORE, THE SDS WAS REMOVED; HOWEVER, THE STENT WAS NOT ON THE BALLOON. THE STENT HAD DISLODGED IN THE PATIENT¿S BODY. A SNARE WAS USED TO RETRIEVE THE DISLODGED STENT, AND AN UNSPECIFIED SDS WAS USED TO SUCCESSFULLY COMPLETE THE PROCEDURE. THERE WAS NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 10373810 ↗MalfunctionApr 8, 2020Difficult to Insert; Material Separation; Deformation Due to Compressive Stress; Difficult to Insert; Material Separation; Deformation Due to Compressive Stress
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT AN UNSPECIFIED LESION. A 3.0X08MM XIENCE SIERRA HAD DIFFICULTY BEING INSERTED ONTO THE GUIDE WIRE. THE TIP WAS NOTED AS BENT THEN BROKE OFF. ANOTHER SAME SIZE XIENCE SIERRA WAS USED TO SUCCESSFULLY COMPLETE THE PROCEDURE. THERE WERE NO ADVERSE PATIENT EFFECTS AND NO CLINICALLY SIGNIFICANT DELAYS. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9934340 ↗InjuryDec 9, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT ON (B)(6) 2019 THE PATIENT PRESENTED WITH NON-ST ELEVATED MYOCARDIAL INFARCTION (NSTEMI) THEREFORE THE 3.0X08MM XIENCE SIERRA WAS IMPLANTED. ON (B)(6) 2019 THE PATIENT WAS RE-ADMITTED WITH OTHER CARDIOVASCULAR SYMPTOMS. IT IS UNKNOWN WHAT TREATMENT WAS PERFORMED AND THE FINAL PATIENT OUTCOME IS UNKNOWN. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Code Available
MAUDE report 9441136 ↗InjuryDec 9, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT ON (B)(6) 2019 THE PATIENT PRESENTED WITH ST ELEVATED MYOCARDIAL INFARCTION (STEMI) THEREFORE THE 3.0X08MM XIENCE SIERRA WAS IMPLANTED. ON (B)(6) 2019 AND (B)(6) 2019 THE PATIENT WAS RE-ADMITTED WITH HYPOGLYCEMIA AND BACTEREMIA. IT IS UNKNOWN WHAT TREATMENT WAS PERFORMED AND THE FINAL PATIENT OUTCOME IS UNKNOWN. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Code Available; Unspecified Infection
MAUDE report 9439243 ↗MalfunctionNov 4, 2019Improper or Incorrect Procedure or Method; Adverse Event Without Identified Device or Use Problem; Improper or Incorrect Procedure or Method; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT THE LEFT MAIN. A 3.0 X 8 MM XIENCE SIERRA STENT WAS IMPLANTED WITHOUT ISSUES; HOWEVER, THE DEVICE HAD ALREADY EXPIRED. THERE WERE NO ADVERSE PATIENT EFFECTS AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9272647 ↗InjuryOct 1, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
SUBSEQUENT TO THE PREVIOUS MEDWATCH REPORT, THE ADDITIONAL INFORMATION WAS RECEIVED: ON (B)(6) 2020, THE PATIENT PRESENTED TO THE EMERGENCY ROOM WITH CHEST PAIN AND SHORTNESS OF BREATH. IMAGING WAS PERFORMED REVEALING AN OCCLUDED LAD, CX, AND RCA. THE LIMA TO THE LAD WAS PATENT AND THE RAMUS HAD IN-STENT RESTENOSIS TREATED WITH BALLOON ANGIOPLASTY. THE EVENT RESOLVED THAT SAME DAY AND THE PATIENT WAS DISCHARGED HOME.
Patient problems: Angina; Dyspnea; Stenosis
MAUDE report 9142228 ↗MalfunctionMar 11, 2019Device Dislodged or Dislocated; Device Dislodged or Dislocated
IT WAS REPORTED THAT THE PROCEDURE WAS PERFORMED TO TREAT A LESION IN THE OBTUSE MARGINAL ARTERY. A 3.0X08MM XIENCE SIERRA STENT DELIVERY SYSTEM (SDS) WAS ADVANCED THROUGH AN 8F GUIDING CATHETER WITHOUT RESISTANCE; HOWEVER, IT WAS DECIDED THAT PRE-DILATATION WAS NEEDED SO THE SDS HAD TO BE REMOVED. NO RESISTANCE REMOVING THE SDS WAS FELT, BUT THE STENT DISLODGED RIGHT OUTSIDE THE GUIDE CATHETER BY THE GROIN AREA. THE DISLODGED STENT WAS SIMPLY REMOVED BY HAND. THE PROCEDURE WAS SUCCESSFULLY COMPLETED WITH A NEW 3.0X08MM XIENCE SIERRA STENT. THERE WERE NO ADVERSE PATIENT EFFECTS AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8408190 ↗
Other Coronary drug-eluting stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page